What is the market doing?
What the tape says about ANAB
AnaptysBio, Inc. is +328% over the past year while the S&P 500 is +23%: 305 points ahead of the market.
+328%
1-year return · S&P 500 +23%
- vs 200-day average
- +35%
vs 200-day average · a clear uptrend
- RSI (14)
- 60
RSI (14) · neutral
- Below its 52-week high
- −17%
Below its 52-week high
Details›
- Last close2026-08-26
- $58.09
- 1 monthS&P 500 +3.7%
- +5.7%
- 1 yearS&P 500 +23%
- +328%
- 5 yearsS&P 500 +87%
- +271%
- vs 50-day average$56.26
- +3.2%
- 52-week high
- $69.82
- 52-week low
- $12.93
- Annualised volatility
- 80%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$6.0M
| Year | Return |
|---|---|
| 2026 (year to date) | +80% |
| 2025 | +266% |
| 2024 | −38% |
| 2023 | −31% |
| 2022 | −11% |
| 2021 | +62% |
| 2020 | +32% |
| 2019 | −75% |
| 2018 | −37% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 9 | 5 of 9 | +3.8% |
| Feb | 10 | 8 of 10 | +8.8% |
| Mar | 10 | 4 of 10 | −5.5% |
| Apr | 10 | 5 of 10 | +10% |
| May | 10 | 4 of 10 | −4.1% |
| Jun | 10 | 6 of 10 | +1.3% |
| Jul | 10 | 5 of 10 | +1.3% |
| Aug | 10 | 6 of 10 | +2.6% |
| Sep | 9 | 5 of 9 | +6.0% |
| Oct | 9 | 6 of 9 | +20% |
| Nov | 9 | 3 of 9 | −4.4% |
| Dec | 9 | 6 of 9 | +5.5% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Biotechnology
Ranks #102 of 145 by Smart Score